Austin Scott
Trade Performance Intelligence
Score: 4/10Performance calculated from trade date to most recent market close. Real-time stock data from Financial Modeling Prep. This is not financial advice.
Stock Price at Trade vs. Today
Real market data showing how each stock moved since the congress member traded it.
Suspicious Timing Detected
2 flagsRep. Austin Scott sold $1,001 - $15,000 in $GEHC on 2025-03-27, 70 days before the 'Supporting Healthy Moms and Babies Act' (HR3762) was introduced. This bill mandates comprehensive maternal care, which could impact healthcare providers.
Rep. Austin Scott sold $1,001 - $15,000 in $GE (GE Aerospace Common Stock) on 2025-06-16, 94 days before the 'Fight Illicit Pill Presses Act' (S2870) was introduced. This bill expands the definition of 'regulated persons' under the Controlled Substances Act, potentially affecting industrial equipment manufacturers.
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| SELL | $BLDP | Ballard Power Systems, Inc. - Common Shares | $1K-$15K | — | — | — | Jul 31, 2024 |
| SELL | $BE | Bloom Energy Corporation Class A Common Stock | $1K-$15K | — | — | — | Jul 15, 2024 |
| SELL | $CLNE | Clean Energy Fuels Corp. - Common Stock | $1K-$15K | — | — | — | Jul 15, 2024 |
| SELL | $F | Ford Motor Company Common Stock | $1K-$15K | — | — | — | Oct 2, 2024 |
| SELL | $F | Ford Motor Company Common Stock | $1K-$15K | — | — | — | Mar 4, 2025 |
| SELL | $GE | GE Aerospace Common Stock | $1K-$15K | — | — | — | May 23, 2025 |
| SELL | $GE | GE Aerospace Common Stock | $1K-$15K | — | — | — | Jun 16, 2025 |
| SELL | $GE | GE Aerospace Common Stock | $1K-$15K | — | — | — | Dec 13, 2024 |
| SELL | $GE | GE Aerospace Common Stock | $1K-$15K | — | — | — | Jan 13, 2025 |
| SELL | $GE | GE Aerospace Common Stock | $1K-$15K | — | — | — | Mar 4, 2025 |
Connected Legislative Activity
7 signalsThese bills and contracts share tickers or sectors with this filing's trades.
A bill to authorize the extension of nondiscriminatory treatment (normal trade relations treatment) to products of certain countries.
S. 3103, an early-stage bill, authorizes the President to extend normal trade relations to most countries, excluding Belarus, Cuba, and North Korea. This action would reduce import costs and lower export barriers for U.S. companies engaged in international trade. The bill is currently referred to the Committee on Finance.
STOP China Act
The STOP China Act (HR4361) aims to prohibit federal funds for vehicles and vehicle technologies from Chinese entities, directing procurement towards US-based manufacturers. This bill is in the early stages, having been referred to two House committees, but has a companion bill (S1711) in the Senate, indicating bipartisan interest. The legislation creates a protected market for American vehicle and component manufacturers in federally funded projects.
CREATE JOBS Act
The CREATE JOBS Act (S.2056) proposes to permanently reinstate 100% bonus depreciation, allowing businesses to immediately deduct the full cost of capital investments. This bill, if enacted, would provide a significant tax incentive for companies across all sectors to increase capital expenditures. The bill is currently in the early stages, having been referred to the Senate Committee on Finance.
Supporting Healthy Moms and Babies Act
The 'Supporting Healthy Moms and Babies Act' (HR3762) has been introduced in the House and referred to three committees. This bill mandates comprehensive coverage for maternal and newborn care without cost-sharing, which would increase revenue for healthcare providers and diagnostic companies, while increasing costs for health insurers. The bill is in its early stages, with a companion bill (S1834) also introduced in the Senate.
Fight Illicit Pill Presses Act
The Fight Illicit Pill Presses Act, S2870, is an early-stage bill that expands the definition of 'regulated persons' under the Controlled Substances Act to include manufacturers, distributors, and brokers of tableting and encapsulating machines and their critical parts. This legislation increases regulatory burdens and compliance costs for industrial machinery producers. The bill has a companion in the House, HR5880, indicating broader legislative interest.
To authorize the extension of nondiscriminatory treatment (normal trade relations treatment) to products of certain countries.
HR5917 authorizes the President to grant normal trade relations (NTR) status to most countries, excluding Belarus, Cuba, and North Korea, by waiving the Jackson-Vanik amendment. This action reduces tariffs and trade barriers for goods from these countries, directly benefiting U.S. importers and consumers through lower costs. Companies relying on global supply chains will see improved margins and increased access to goods.
SEPSIS Act
The SEPSIS Act (S.1929) establishes new federal programs for sepsis research, diagnosis, and treatment, creating new revenue streams for medical diagnostics, device manufacturers, and clinical research companies. Senate Majority Leader Schumer's sponsorship and a House companion bill (HR7116) indicate strong legislative momentum for this early-stage bill. The bill does not specify a funding amount, but authorizes programs that would require future appropriations.
Live Charts
Other Filings by Austin Scott
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.